Sabra Health Care REIT (SBRA) Misses Q4 EPS by 6c; offers guidance

Sabra Health Care REIT (NASDAQ: SBRA) reported Q4 EPS of $0.07, $0.06 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $163.4 million versus the consensus estimate of $162.91 million.

GUIDANCE:

Sabra Health Care REIT sees FY2024 EPS of $0.53-$0.57, versus the consensus of $0.58.

Normalized AFFO: $1.39 - $1.43

For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c